{
    "title": "Novo Nordisk, Pfizer weight-loss pills work as well as shots",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12111843/Novo-Nordisk-says-trial-oral-weight-loss-drug-shows-significant-result.html",
    "date": "2023-05-22",
    "keywords": [
        "loss",
        "novo",
        "nordisk",
        "drug",
        "wegovy",
        "louise",
        "weight",
        "semaglutide",
        "market",
        "company",
        "year",
        "pill",
        "treatment",
        "monday",
        "boost",
        "trial",
        "pfizer",
        "demand",
        "analyst",
        "tablet",
        "capacity",
        "injection",
        "rasmussen",
        "michael",
        "copenhagen",
        "inc",
        "data",
        "class",
        "latestage",
        "version",
        "comparable",
        "ingredient",
        "weightloss",
        "june",
        "attention",
        "companys",
        "midstage",
        "compound",
        "ozempic",
        "share",
        "danuglipron",
        "meeting",
        "decade",
        "industry",
        "pie",
        "slice",
        "cantor",
        "chen",
        "research",
        "note",
        "capital",
        "seigerman",
        "efficacy",
        "lillys",
        "competitor",
        "mounjaro",
        "care",
        "drugmaker",
        "approval",
        "launch",
        "milligram",
        "portfolio",
        "study",
        "average",
        "placebo",
        "choice",
        "obesity",
        "opportunity",
        "head",
        "development",
        "profile",
        "impact",
        "time",
        "dose",
        "spokesperson",
        "prescription",
        "breusch",
        "reporting",
        "boleslaw",
        "lasocki",
        "maggie",
        "fick",
        "editing",
        "paul",
        "simao",
        "conor",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}